| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | TGFBI/POSTN | 1.27e-05 | 2 | 67 | 2 | IPR016666 | |
| Domain | FAS1 | 7.57e-05 | 4 | 67 | 2 | SM00554 | |
| Domain | FAS1_domain | 7.57e-05 | 4 | 67 | 2 | IPR000782 | |
| Domain | - | 7.57e-05 | 4 | 67 | 2 | 2.30.180.10 | |
| Domain | FAS1 | 7.57e-05 | 4 | 67 | 2 | PS50213 | |
| Domain | Fasciclin | 7.57e-05 | 4 | 67 | 2 | PF02469 | |
| Domain | AIG1 | 3.50e-04 | 8 | 67 | 2 | PF04548 | |
| Domain | G_AIG1 | 3.50e-04 | 8 | 67 | 2 | IPR006703 | |
| Domain | G_AIG1 | 3.50e-04 | 8 | 67 | 2 | PS51720 | |
| Domain | HMG_box | 9.09e-04 | 53 | 67 | 3 | PF00505 | |
| Domain | HMG_BOX_2 | 9.60e-04 | 54 | 67 | 3 | PS50118 | |
| Domain | HMG | 9.60e-04 | 54 | 67 | 3 | SM00398 | |
| Domain | - | 1.01e-03 | 55 | 67 | 3 | 1.10.30.10 | |
| Domain | EMI_domain | 1.47e-03 | 16 | 67 | 2 | IPR011489 | |
| Domain | HMG_box_dom | 1.64e-03 | 65 | 67 | 3 | IPR009071 | |
| Domain | EMI | 1.67e-03 | 17 | 67 | 2 | PS51041 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 21871872 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 26288337 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 24747072 | ||
| Pubmed | TGFBI functions similar to periostin but is uniquely dispensable during cardiac injury. | 3.88e-06 | 2 | 69 | 2 | 28750100 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 24368280 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 30048528 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 24484994 | ||
| Pubmed | Genome-wide atlas of gene expression in the adult mouse brain. | 4.16e-06 | 54 | 69 | 4 | 17151600 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 18627005 | ||
| Pubmed | Glucose-Mediated N-glycosylation of SCAP Is Essential for SREBP-1 Activation and Tumor Growth. | 1.16e-05 | 3 | 69 | 2 | 26555173 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 29117645 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 15085196 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 23735324 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | 1.18e-05 | 908 | 69 | 10 | 19274049 | |
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 19478074 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 12202038 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 37357460 | ||
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 11964296 | ||
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 18195716 | ||
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 16100574 | ||
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 12242332 | ||
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 15907457 | ||
| Pubmed | Endoplasmic reticulum factor ERLIN2 regulates cytosolic lipid content in cancer cells. | 3.86e-05 | 5 | 69 | 2 | 22690709 | |
| Pubmed | The gene-gene interaction of INSIG-SCAP-SREBP pathway on the risk of obesity in Chinese children. | 3.86e-05 | 5 | 69 | 2 | 25028659 | |
| Pubmed | Unsaturated fatty acids inhibit proteasomal degradation of Insig-1 at a postubiquitination step. | 5.79e-05 | 6 | 69 | 2 | 18835813 | |
| Pubmed | There exist at least 30 human G-protein-coupled receptors with long Ser/Thr-rich N-termini. | 8.09e-05 | 7 | 69 | 2 | 12565841 | |
| Pubmed | Genetic profile of insertion mutations in mouse leukemias and lymphomas. | 8.09e-05 | 7 | 69 | 2 | 10673281 | |
| Pubmed | Erlins restrict SREBP activation in the ER and regulate cellular cholesterol homeostasis. | 8.09e-05 | 7 | 69 | 2 | 24217618 | |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 1.03e-04 | 544 | 69 | 7 | 28473536 | |
| Pubmed | 1.08e-04 | 8 | 69 | 2 | 11814688 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 1.24e-04 | 1201 | 69 | 10 | 35696571 | |
| Pubmed | 1.38e-04 | 9 | 69 | 2 | 33406432 | ||
| Pubmed | Comparative analysis of the human gimap gene cluster encoding a novel GTPase family. | 1.38e-04 | 9 | 69 | 2 | 15474311 | |
| Pubmed | 1.62e-04 | 257 | 69 | 5 | 16335952 | ||
| Pubmed | IAN family critically regulates survival and development of T lymphocytes. | 1.73e-04 | 10 | 69 | 2 | 16509771 | |
| Pubmed | 1.80e-04 | 263 | 69 | 5 | 20932939 | ||
| Pubmed | 1.87e-04 | 142 | 69 | 4 | 30809309 | ||
| Pubmed | 2.03e-04 | 57 | 69 | 3 | 21122108 | ||
| Pubmed | A survey of protein tyrosine kinase mRNAs expressed in normal human melanocytes. | 2.11e-04 | 11 | 69 | 2 | 8247543 | |
| Pubmed | 2.53e-04 | 12 | 69 | 2 | 18296617 | ||
| Pubmed | 2.53e-04 | 12 | 69 | 2 | 18519639 | ||
| Pubmed | Dual role of DMXL2 in olfactory information transmission and the first wave of spermatogenesis. | 3.48e-04 | 14 | 69 | 2 | 30735494 | |
| Pubmed | 5.13e-04 | 709 | 69 | 7 | 22988430 | ||
| Pubmed | 5.18e-04 | 17 | 69 | 2 | 20856818 | ||
| Pubmed | Circular rapid amplification of cDNA ends for high-throughput extension cloning of partial genes. | 6.35e-04 | 84 | 69 | 3 | 15203218 | |
| Pubmed | 6.49e-04 | 19 | 69 | 2 | 26685326 | ||
| Pubmed | 6.49e-04 | 19 | 69 | 2 | 35514236 | ||
| Pubmed | 7.20e-04 | 20 | 69 | 2 | 27008858 | ||
| Pubmed | β-catenin regulates Pax3 and Cdx2 for caudal neural tube closure and elongation. | 7.95e-04 | 21 | 69 | 2 | 24284205 | |
| Pubmed | 8.73e-04 | 22 | 69 | 2 | 15084671 | ||
| Pubmed | 1.13e-03 | 25 | 69 | 2 | 22438573 | ||
| Pubmed | Deficient signaling via Alk2 (Acvr1) leads to bicuspid aortic valve development. | 1.13e-03 | 25 | 69 | 2 | 22536403 | |
| Pubmed | Compartment-dependent activities of Wnt3a/β-catenin signaling during vertebrate axial extension. | 1.32e-03 | 27 | 69 | 2 | 25152336 | |
| Pubmed | 1.42e-03 | 28 | 69 | 2 | 28218627 | ||
| Pubmed | The human and mouse repertoire of the adhesion family of G-protein-coupled receptors. | 1.52e-03 | 29 | 69 | 2 | 15203201 | |
| Pubmed | 1.52e-03 | 29 | 69 | 2 | 22972626 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 1.52e-03 | 1105 | 69 | 8 | 35748872 | |
| Pubmed | A Tgfbr1/Snai1-dependent developmental module at the core of vertebrate axial elongation. | 1.63e-03 | 30 | 69 | 2 | 32597756 | |
| Pubmed | AMPK Interactome Reveals New Function in Non-homologous End Joining DNA Repair. | 1.82e-03 | 121 | 69 | 3 | 31900314 | |
| Pubmed | 1.85e-03 | 32 | 69 | 2 | 19815544 | ||
| Pubmed | International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors. | 1.97e-03 | 33 | 69 | 2 | 25713288 | |
| Pubmed | 1.97e-03 | 33 | 69 | 2 | 24727668 | ||
| Interaction | NUP205 interactions | 1.16e-05 | 235 | 66 | 7 | int:NUP205 | |
| GeneFamily | Phospholipases | 1.76e-04 | 42 | 47 | 3 | 467 | |
| GeneFamily | GTPases, IMAP | 1.83e-04 | 8 | 47 | 2 | 580 | |
| GeneFamily | Immunoglobulin like domain containing | 1.57e-03 | 193 | 47 | 4 | 594 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 4.84e-03 | 40 | 47 | 2 | 321 | |
| GeneFamily | Forkhead boxes | 5.58e-03 | 43 | 47 | 2 | 508 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.Sp, TCRd+ CD3e+, Spleen, avg-3 | 3.22e-05 | 393 | 67 | 8 | GSM476672_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_ReproVasc_Flk_top-relative-expression-ranked_1000 | LGMN SOX7 HIVEP2 GIMAP8 GIMAP5 SLCO2A1 CD68 LIPT2 DRAM2 ADGRA2 ADGRG6 | 4.59e-05 | 817 | 67 | 11 | gudmap_dev gonad_e11.5_F_ReproVasc_Flk_1000 |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#4_top-relative-expression-ranked_1000 | 7.03e-05 | 136 | 67 | 5 | gudmap_kidney_adult_RenalCapsule_k4_1000 | |
| ToppCell | LAM-Endothelial-VasEndo-2|LAM / Condition, Lineage and Cell class | 2.22e-08 | 195 | 69 | 7 | bd11d771938251c091a50d559a2c38d1c4a04033 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-08 | 196 | 69 | 7 | dbf154b3d166ffd07be717dac8d8a3350ac63e16 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_macrophage-stroma-monocytoid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.44e-07 | 178 | 69 | 6 | e44b0aa82890ae84fc4d1343f1c65ae2fda69a11 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.91e-07 | 182 | 69 | 6 | 16186b7a0c33caa48631962381e3ab7e5d166163 | |
| ToppCell | Endothelial-A-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 4.59e-07 | 187 | 69 | 6 | fd93f3f4b82dae3bf4eef245bfedc2a9e3251b61 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.86e-07 | 195 | 69 | 6 | 023e3c97dd3696d74f002ff8da0c04d876c82aef | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_macrophage|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.41e-07 | 198 | 69 | 6 | 9aaff68107ae4542f904b142d23669f2fcd557ac | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.41e-07 | 198 | 69 | 6 | 5aaf3861c53763cf09bb628c9d2eabb6a7277021 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.60e-07 | 199 | 69 | 6 | d66514bdffdd96468b543ec96041e42c12472e66 | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX-MoAM-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 6.60e-07 | 199 | 69 | 6 | fb63885273d906a85fef178d859d20a311eb8a72 | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.80e-07 | 200 | 69 | 6 | 74a3b9ec8faa1d187ad8b0d12f5c89bde2d7248e | |
| ToppCell | cellseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.80e-07 | 200 | 69 | 6 | 13f6ac0dfc9206dd2e6cbd84357a5883952ee5c7 | |
| ToppCell | Biopsy_Control_(H.)-Endothelial|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 6.80e-07 | 200 | 69 | 6 | 6a9b6a4b4f204598290ae21c87ddb42ac95dfc4c | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 6.80e-07 | 200 | 69 | 6 | 9e5627e11288713aa9b622aae40e849dd6eacd29 | |
| ToppCell | Biopsy_Control_(H.)-Endothelial-Endothelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 6.80e-07 | 200 | 69 | 6 | 0242d465da2dfba0da629a43e152949c5192465b | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.09e-06 | 145 | 69 | 5 | 37580218f6a6f65a1d827cbcf59465f8827f9a55 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.53e-06 | 149 | 69 | 5 | d9c47f523c75ddcd6131e45d2ffc24b970932cae | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.00e-06 | 160 | 69 | 5 | 636127753e3a22831f39d4c8170df40901e4329d | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.00e-06 | 160 | 69 | 5 | cb8d0dc1a6c69c7a85c5fdd8f0f6cca1b73dfc63 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Myeloid|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.80e-06 | 165 | 69 | 5 | 518ee34c18065100a2f2c6e407d3a7866b908593 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Myeloid-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.80e-06 | 165 | 69 | 5 | becb8f726b84509ec29c75b530a3fe757651301d | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 5.80e-06 | 165 | 69 | 5 | 7d319a112b9062efee428bef6f4534d2ce782e04 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Myeloid-macrophage|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.80e-06 | 165 | 69 | 5 | ae8dd9c00f96590f27ed21cd6314f4577e00e312 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l12|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.98e-06 | 166 | 69 | 5 | 7be2b5c62e2be3437ea50b9a473cf9fc7f05e0b1 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-interstitial_macrophage|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.98e-06 | 166 | 69 | 5 | 8418b191e7f16cb39301df3ddbfb1bab6c0632d6 | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|World / disease group, cell group and cell class (v2) | 6.15e-06 | 167 | 69 | 5 | bf08f17965a4dd03f371b4ed0ab0d5e62ed61307 | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 6.34e-06 | 168 | 69 | 5 | 968405ea56f7d001ef83ff9274610923c3b2d55d | |
| ToppCell | COVID_vent-Lymphocytic-Dendritic-pDC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 6.90e-06 | 171 | 69 | 5 | 779c951d274ecbd1d546ac425d6c8e718623be5a | |
| ToppCell | COVID_vent-Lymphocytic-Dendritic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 6.90e-06 | 171 | 69 | 5 | debbb071d260639b16269c94d172766908325c58 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Myeloid-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.90e-06 | 171 | 69 | 5 | d9ad6a3bce3556abd24af1630bf4a99594437c3a | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.10e-06 | 172 | 69 | 5 | 979fd7b435f59b8a4d290a809cf76147d4c63d48 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.10e-06 | 172 | 69 | 5 | f4d7f416802218ce56408fa4cb8a555d846bc85b | |
| ToppCell | 390C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 7.31e-06 | 173 | 69 | 5 | 1f725ff16e28636b20ef26f3fa9be8b47c89378d | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.51e-06 | 174 | 69 | 5 | 6b5ff1cc5fe6705f7ea70b5a892dfbf91e32288d | |
| ToppCell | 10x5'-blood-Myeloid_Dendritic|blood / Manually curated celltypes from each tissue | 7.72e-06 | 175 | 69 | 5 | 1c48eec300d5a6d4a810947b995af3b8c0a5a601 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.94e-06 | 176 | 69 | 5 | 87de432c680b80555342afac864599bbc002c040 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.16e-06 | 177 | 69 | 5 | 382f0d6bbff01e84b0c7840e74ac865864e6da89 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma-monocytoid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.16e-06 | 177 | 69 | 5 | 945b2d0723a0a35c767604ae607d2c2d53bf0c82 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 8.85e-06 | 180 | 69 | 5 | 7be7d7a6906fff6dbdecd9cb013d855aba4eda2a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.85e-06 | 180 | 69 | 5 | 6f8fa9fa91cd25b92584972bb34d90c483222f52 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.10e-06 | 181 | 69 | 5 | a5e770b5b5d57cbac18560828e89f7c96b687743 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.10e-06 | 181 | 69 | 5 | 504b1af1951a7a20ef5db69d84c20630ec64095b | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.10e-06 | 181 | 69 | 5 | a55ec36d2393f7a376feb42b22aee75dfdf4c383 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.34e-06 | 182 | 69 | 5 | d0e3663f7d39f22a3ebd7fde56ab3504773598f4 | |
| ToppCell | (7)_DC_plasmacytoid|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 9.59e-06 | 183 | 69 | 5 | 2c6475c935b5a90931be6b3c53f1f707cfcd11f4 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_prolif-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.85e-06 | 184 | 69 | 5 | 65b00145cb7da7d64eb6765569573c1a902a1036 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-CD163+CD14+_DCs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 9.85e-06 | 184 | 69 | 5 | 2dc4b2a9970111ed5e2977fc178595a12d7bb59d | |
| ToppCell | Endothelial-A-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 1.01e-05 | 185 | 69 | 5 | dee0b7ba2f338f0979d2306aedf52ac35a36b60c | |
| ToppCell | Endothelial-A-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 1.04e-05 | 186 | 69 | 5 | 796cbae2a417502aaf0891fc9c382bbfd88967fe | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.04e-05 | 186 | 69 | 5 | c7e2134454ab5d0885050dd1bb3c3bd15bf497ac | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(other)|Control / group, cell type (main and fine annotations) | 1.04e-05 | 186 | 69 | 5 | c6075fe84226b370c5139066793844ad33ae2db1 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.06e-05 | 187 | 69 | 5 | 387cb27c8a20031cd87381a9e1172f1f62e1488b | |
| ToppCell | 10x5'-GI_large-bowel-Myeloid_Monocytic|GI_large-bowel / Manually curated celltypes from each tissue | 1.09e-05 | 188 | 69 | 5 | d0045fdda757d191dabc7853f6a6e99c0e97d93d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.09e-05 | 188 | 69 | 5 | 3f47395db7e6159fc95810545bad4b6e028464c5 | |
| ToppCell | 10x5'-GI_large-bowel-Myeloid_Monocytic-Classical_monocytes|GI_large-bowel / Manually curated celltypes from each tissue | 1.09e-05 | 188 | 69 | 5 | 0bcf04aa47738f43c1a87dae5dc487738ee86f8c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.09e-05 | 188 | 69 | 5 | 4d1e5f85342ae550086609d7680e32730b78b5d2 | |
| ToppCell | COVID-19_Mild-pDC|COVID-19_Mild / Disease condition and Cell class | 1.09e-05 | 188 | 69 | 5 | 62d33d2990d4a2d32bd0863147e47f656df1966e | |
| ToppCell | COVID-19_Mild-pDC-|COVID-19_Mild / Disease condition and Cell class | 1.09e-05 | 188 | 69 | 5 | a75c2cf2f8dae343c13aaa66b637658b935ed10a | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.12e-05 | 189 | 69 | 5 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 189 | 69 | 5 | 6f0fc5271a7d3682f145e734abc3be6473dda2e2 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-APOE+_Mac2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.12e-05 | 189 | 69 | 5 | e189ef6066f87177d758f0e3ed9a17e01031a391 | |
| ToppCell | Control-Myeloid-pDC|Control / Disease group, lineage and cell class | 1.12e-05 | 189 | 69 | 5 | 46770b99da42f11f10cfc67cea8562342d60b867 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.12e-05 | 189 | 69 | 5 | 0abc7a4900cc9033bc1be69b770ccc54a6bf41b4 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 189 | 69 | 5 | 3b9ce8964b16cb2200d30cbb0bfc711dcad2380e | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 189 | 69 | 5 | 38acb307907fde68b992057714448c1561d69ee3 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.15e-05 | 190 | 69 | 5 | d24af6af3271e34afab744352afd28be8a7cc5c3 | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 190 | 69 | 5 | 6f71a9f74af7cd9a674753cfc9833ebe5bba0fa2 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.15e-05 | 190 | 69 | 5 | 591310e615700321a010a4b90405cbbbbdb3aade | |
| ToppCell | Control-pDC|Control / Disease condition and Cell class | 1.18e-05 | 191 | 69 | 5 | 543e1437a52d04436862dd1c27b4fae95c44fcc8 | |
| ToppCell | COVID-19_Moderate-pDC|COVID-19_Moderate / disease group, cell group and cell class | 1.18e-05 | 191 | 69 | 5 | 9d0ffa65c547e20b4076fd97776d7738cbd453ec | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-05 | 191 | 69 | 5 | 4bfdf44d4402a42530d30c89d94946acdda4321b | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Control / Disease state, Lineage and Cell class | 1.18e-05 | 191 | 69 | 5 | 322237793a1278bafb14e63cab688b353e352dcc | |
| ToppCell | Control-pDC-|Control / Disease condition and Cell class | 1.18e-05 | 191 | 69 | 5 | 1d7b0fae4d114d6db933c18b4eb2066ffa61356d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.18e-05 | 191 | 69 | 5 | b5715eeb72a97b7bc87b83f6c289e225f58da842 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 1.21e-05 | 192 | 69 | 5 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | tumor_Lung-Endothelial_cells-Stalk-like_ECs|tumor_Lung / Location, Cell class and cell subclass | 1.24e-05 | 193 | 69 | 5 | 21fec35587ffb5c0157e54a821ce3ffd3e24e536 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.24e-05 | 193 | 69 | 5 | 697518bab1338dc441b2d93b410d957e692f20e6 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.24e-05 | 193 | 69 | 5 | 2f203f6f0c2135acb046c9351a633c3b5b254a46 | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-conventional_dendritic_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.24e-05 | 193 | 69 | 5 | 984ea5b871479527ab57dd813bacae844c0d8c06 | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.24e-05 | 193 | 69 | 5 | b7c0b4dbbe11f86cff6371d3d12a6b772b938d78 | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.24e-05 | 193 | 69 | 5 | e44d777f65b907f299cefd73296805ac4c92d383 | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-conventional_dendritic_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.24e-05 | 193 | 69 | 5 | 529281b912070c8655e38880ac73f5e4bd6ee4ce | |
| ToppCell | myeloid-macrophage|World / Lineage and Cell class | 1.24e-05 | 193 | 69 | 5 | b13e694123b87ed8ad1786feb996398ddd84e94b | |
| ToppCell | Endothelial-A-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.27e-05 | 194 | 69 | 5 | abea887dd472c1a0d572e690bc8914c1b94712ad | |
| ToppCell | Monocytes-M2-like_CD16+_macrophages|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.30e-05 | 195 | 69 | 5 | 10fa47bdcf6c9784ea930b75a5861e139421feed | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.30e-05 | 195 | 69 | 5 | c16479a10f5ca2e89aea1742dbc5cc4dc9f3ea88 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.30e-05 | 195 | 69 | 5 | 9a9e074f7ac04656dccbed2f0df11377e33d3c05 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.34e-05 | 196 | 69 | 5 | e0447ad2efb021b63c7fef000d39b6b21fbe6113 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.34e-05 | 196 | 69 | 5 | efdc95811e8b17243065ae82d748ea2c5775fdbc | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.34e-05 | 196 | 69 | 5 | 3392efa5007736b1e87f34805c16e8baa792e596 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_macrophage-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.34e-05 | 196 | 69 | 5 | bd2c2de103e28b65ea537c22f71225cb0deef1e0 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Macroglial-Glia_progenitor_cell|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 1.34e-05 | 196 | 69 | 5 | 7be50b9156394dea44d7b8b476d4dd516abfafae | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.34e-05 | 196 | 69 | 5 | 889c9fed857f64664ca1f47fcec9fecb15ed103c | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.34e-05 | 196 | 69 | 5 | 686533fd3fba8e4df96b9dd1307e870e89db4332 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.34e-05 | 196 | 69 | 5 | 3bca88eede3dd7368715ced02e3bacd1e3e82cab | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.34e-05 | 196 | 69 | 5 | 072a4150ae521c6589b0f7cd60e975fb33715bf4 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_macrophage-stroma-stromal_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.34e-05 | 196 | 69 | 5 | 88517bb92be2f05c1e1ad94af22ac10d8c5c13c7 | |
| ToppCell | MatrixFB-Fibroblast-B_(Myofibroblast)|MatrixFB / shred on cell class and cell subclass (v4) | 1.34e-05 | 196 | 69 | 5 | 38ea0eaf42f95c321ca23570d0d7752980cf00f8 | |
| ToppCell | (7)_Macrophage|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.34e-05 | 196 | 69 | 5 | f1c822860d2a0bae84b0263b0151185756423e0f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.34e-05 | 196 | 69 | 5 | e54c08f88779f9fd453a4f5b85aed1f460d8a1e1 | |
| Disease | scoliosis (implicated_via_orthology) | 4.61e-05 | 5 | 64 | 2 | DOID:0060249 (implicated_via_orthology) | |
| Disease | Attached earlobe | 1.29e-04 | 8 | 64 | 2 | HP_0009907 | |
| Disease | response to clopidogrel, response to acetylsalicylate, major adverse cardiovascular event measurement | 1.65e-04 | 9 | 64 | 2 | EFO_0020863, GO_1903492, GO_1903493 | |
| Disease | outer ear morphology trait | 3.01e-04 | 12 | 64 | 2 | EFO_0007664 | |
| Disease | hair colour measurement | 3.67e-04 | 615 | 64 | 7 | EFO_0007822 | |
| Disease | lobe size | 4.14e-04 | 14 | 64 | 2 | EFO_0007666 | |
| Disease | idiopathic scoliosis (implicated_via_orthology) | 5.45e-04 | 16 | 64 | 2 | DOID:0060250 (implicated_via_orthology) | |
| Disease | kidney disease (biomarker_via_orthology) | 9.47e-04 | 21 | 64 | 2 | DOID:557 (biomarker_via_orthology) | |
| Disease | revision of total joint arthroplasty | 1.69e-03 | 28 | 64 | 2 | EFO_0020974 | |
| Disease | birth weight | 1.75e-03 | 399 | 64 | 5 | EFO_0004344 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HLYLQRGACKTPPDG | 121 | Q9H161 | |
| GCPAALPLSNLYETL | 96 | Q15582 | |
| RPHSEAAYTLGPLLC | 771 | Q9BZ76 | |
| PAGLFAHTPCLVGLS | 281 | P22792 | |
| HLLTADHGPPRLSYC | 116 | Q6P1X6 | |
| YEVLPSHTCGNPGRL | 131 | Q7Z408 | |
| GAGLHPVVYPCTALL | 766 | Q96PE1 | |
| CGSYLIPLPAAELAS | 356 | Q86SQ4 | |
| LPPFVGLCASLAGHS | 3996 | Q96M86 | |
| AGYGCPLLSDLTLSP | 1536 | Q5TGY3 | |
| YCVSGLPVSLPTHAR | 331 | P51828 | |
| LPGTSAYRKLCPHGS | 2341 | Q75N90 | |
| CLPATCGLPAEYATH | 1406 | O14578 | |
| AISCHPYQPLIAIGS | 611 | Q8TBY9 | |
| VQLHCLYGTGVPTPD | 326 | Q8NCC3 | |
| SCEGAHPHLLLSFPY | 206 | P34810 | |
| PIGHLYIFATCLGLS | 171 | P43357 | |
| TLALGPLYESPCVHA | 281 | Q5MY95 | |
| GLICGPCFSSLPEHL | 956 | Q9H252 | |
| AGHHSLALCPELAPY | 1186 | Q12766 | |
| SARTLLYAHGPPVTC | 376 | Q8N3Y1 | |
| LYAHGPPVTCLDVSA | 381 | Q8N3Y1 | |
| CHPTPGLSGINLTTY | 71 | Q9BYR8 | |
| LYSLPICGPNVIDHS | 161 | Q8NH70 | |
| LHGLTLYDTAPCPIN | 241 | Q6UX65 | |
| GLLYPCIDSHLGEPH | 141 | O15503 | |
| LYLTCHGPTAAPEGT | 1351 | Q5T7B8 | |
| LFHRGEYSASPLCLP | 681 | Q9BXB1 | |
| RCSGPGLPLYTLHSS | 471 | P27487 | |
| PYIGSSPTFCHLLHE | 676 | Q6UVM3 | |
| LPFTVYCLLGDAHSP | 261 | P46089 | |
| CVACLAPPAGSVLYH | 86 | Q8N4S7 | |
| YGVPLKPLCHAAGQT | 241 | Q99853 | |
| GDCYLLSAPGPHVLL | 101 | Q96F15 | |
| PPTLCTAISHGIYYL | 256 | Q7RTM1 | |
| PGCLLYTKTGSAPHL | 31 | Q9H974 | |
| YHALLIPSCPGALTD | 86 | Q8NB37 | |
| HGLYTDPCGVVLDPS | 191 | Q9NWS6 | |
| QGTCEYLLSAPCHGP | 2091 | Q9Y6R7 | |
| CTGPHAFLLVTPLGF | 321 | Q8ND71 | |
| AALYSHPLPESCLGE | 126 | Q9NYD6 | |
| AAAPSCAGYNPGLLL | 11 | A6NH13 | |
| AAGGAHLYCPLRLPA | 366 | Q9C009 | |
| ALLLCEPAGPVYTAG | 46 | A6NK58 | |
| SPGTALPSLRGCYHE | 166 | Q9BT81 | |
| LGLGHTEDIPYFTPC | 81 | Q9UGK8 | |
| SLPVILEPSYNHSGC | 376 | Q8NB59 | |
| LGKGTLTLCPYHSDR | 771 | Q13200 | |
| GCSIPLHSLEAGIYP | 1351 | P08F94 | |
| SLLCFLSPVGPHTLG | 101 | Q5H9E4 | |
| CHLTKAVPGNPLGYL | 31 | Q9NZ20 | |
| HAEALLLASCYLPPG | 1086 | P36956 | |
| LPSPALYGLTIDHSC | 566 | Q92959 | |
| CYLGPHLSHDPILFA | 436 | Q8NI27 | |
| APYGSVSPLHLRCNI | 811 | Q9C0A1 | |
| LSPYPVILSLENHCG | 421 | Q8N3E9 | |
| CLYFIAPSGHGLKPL | 161 | Q16181 | |
| PELLCLVSHFYPSGG | 311 | O15533 | |
| TPGLSGIYPLTHCTL | 246 | P30530 | |
| CGGPSAEAYLLHPAA | 341 | O95947 | |
| YHSLCHGLTPNGLLP | 101 | Q96NM4 | |
| VHLTALGYTLCGLRP | 1586 | A6NGW2 | |
| SLCFVLPLAAPGHGT | 6 | Q8WU66 | |
| LCPSPDGLHLAVGYE | 71 | Q9UNX4 | |
| GCPAVLPIDHVYGTL | 91 | Q15063 | |
| CYSGASGLHPKNLLP | 1281 | P31629 | |
| TLRPAGPEHSGLYSC | 186 | Q13308 | |
| YPCGGTPESSLHEAL | 11 | Q5SRH9 | |
| ASGSLCGPHAKAPYL | 51 | Q6UXU0 | |
| LLSERAPLTGHSCYP | 366 | Q99538 | |
| APLTGHSCYPEALLH | 371 | Q99538 | |
| PSHPYGITLLNCDGH | 711 | P54296 |